Clinical Trial
Disease
Disease type
Stargardt Disease
Orphan drug recognition
No
Patient type
Adult
Children
Inclusion / Exclusion
Funding
industry
Members involved
Main investigators
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/09/john-doe.jpg)
PD Dr Markus Preising
Representative
Germany
Pediatric Ophthalmology Rare Diseases (WG3), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Others investigators
ERN EYE member investigating site
HCP : Principal investigators
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/11/Quinze-Vingts-CHN03-430x160.jpg)
RÉFÉRET National Hospital of Ophthalmology of Quinze-Vingts, Paris, France
Adress
28 Rue de Charenton
75012 Paris
France
![](https://www.ern-eye.eu/wp-content/uploads/sites/2/2023/11/CON_534553936_M.jpg.33045795-430x160.jpg)
Universitätsklinikum Gießen und Marburg GmbH, Gießen, Germany
Adress
Klinik und Poliklinik für Augenheilkunde Friedrichstr. 18
35392 Gießen
Germany